Related Experiment Video
Updated: Aug 17, 2026

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants
Published on: May 4, 2018
PER-1 is still widespread in Turkish hospitals among Pseudomonas aeruginosa and Acinetobacter spp
Fetiye Kolayli1, Gulcin Gacar, Aynur Karadenizli
1Mikrobiyoloji ve Klinik Mikrobiyoloji AD, Kocaeli Universitesi, Turkey.
Abstract:
PER-1 type beta-lactamases were screened among ceftazidime-resistant clinical isolates of Acinetobacter spp. and Pseudomonas aeruginosa. A total of 176 non-repetitive isolates (84 Acinetobacter spp. and 92 P. aeruginosa) were collected during a three month surveillance period. Isolates were obtained from seven intensive care units of seven university hospitals. All strains were screened for bla(PER-1) alleles by PCR. Of the strains, 31% and 55.4% of Acinetobacter spp. and P. aeruginosa were positive for bla(PER-1) type genes, respectively.
Insights
The PER-1 beta-lactamase gene was detected in 31% of ceftazidime-resistant Acinetobacter spp. and 55.4% of Pseudomonas aeruginosa clinical isolates. This highlights the prevalence of this resistance mechanism in intensive care units.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Beta-lactamases are enzymes that confer resistance to beta-lactam antibiotics.
- PER-1 type beta-lactamases are a significant cause of resistance to third-generation cephalosporins like ceftazidime.
- Acinetobacter spp. and Pseudomonas aeruginosa are common Gram-negative pathogens often associated with hospital-acquired infections and multidrug resistance.
Purpose of the Study:
- To screen for the presence of PER-1 type beta-lactamases in clinical isolates of Acinetobacter spp. and Pseudomonas aeruginosa.
- To determine the prevalence of the bla(PER-1) gene in ceftazidime-resistant strains of these bacteria.
- To assess the potential contribution of PER-1 beta-lactamases to ceftazidime resistance in intensive care unit (ICU) settings.
Main Methods:
- Collection of 176 non-repetitive clinical isolates (84 Acinetobacter spp., 92 P. aeruginosa) from seven university hospital ICUs over three months.
- Screening of all isolates for the presence of bla(PER-1) alleles using the polymerase chain reaction (PCR) technique.
- Phenotypic confirmation of ceftazidime resistance in the selected isolates.
Main Results:
- The bla(PER-1) gene was detected in 31% of the tested Acinetobacter spp. isolates.
- A higher prevalence of the bla(PER-1) gene was observed in Pseudomonas aeruginosa, with 55.4% of isolates testing positive.
- These findings indicate a significant presence of PER-1 beta-lactamase-producing strains among ceftazidime-resistant Acinetobacter and P. aeruginosa in the studied ICUs.
Conclusions:
- PER-1 type beta-lactamases are prevalent among ceftazidime-resistant Acinetobacter spp. and Pseudomonas aeruginosa in clinical settings.
- The high prevalence, particularly in P. aeruginosa, suggests a substantial role for PER-1 in mediating resistance to ceftazidime.
- These results underscore the importance of surveillance for beta-lactamase-producing organisms in ICUs to guide antimicrobial therapy and infection control strategies.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Atypical Pneumonia
Acute Pyelonephritis I: Introduction
Clinical Significance of Antibiotic Resistance
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...